Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lacave

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2008
Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapyP J Fonseca, E Esteban, P de Vicente, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ B Vermorken, J P Armand, A J Lacave, et al.
Investigational New Drugs|July 22, 2005
Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combinationEmilio Esteban-Gonzalez, Yolanda Fernández, Noemí Villanueva, et al.
Investigational New Drugs|August 31, 2002
Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancerEmilio Esteban, Joaquín Fra, Marian Sala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1991
Inefficiency of cisplatin plus 5-FU as second-or third line treatment in advanced breast cancerI Palacio, J M Buesa, F J Barón, et al.
Breast Cancer Research and Treatment|February 16, 2000
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancerE Estaban, A J Lacave, J L Fernández, et al.
Gynecologic Oncology|June 1, 1990
Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG)K R Durrant, C Mangioni, A J Lacave, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group studyJ B Vermorken, G Zanetta, C F De Oliveira, et al.
The New England Journal of Medicine|March 9, 1995
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of CancerM E van der Burg, M van Lent, M Buyse, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group StudyC F de Oliveira, A J Lacave, C Villani, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2008
Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapyP J Fonseca, E Esteban, P de Vicente, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ B Vermorken, J P Armand, A J Lacave, et al.
Investigational New Drugs|July 22, 2005
Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combinationEmilio Esteban-Gonzalez, Yolanda Fernández, Noemí Villanueva, et al.
Investigational New Drugs|August 31, 2002
Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancerEmilio Esteban, Joaquín Fra, Marian Sala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1991
Inefficiency of cisplatin plus 5-FU as second-or third line treatment in advanced breast cancerI Palacio, J M Buesa, F J Barón, et al.
Breast Cancer Research and Treatment|February 16, 2000
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancerE Estaban, A J Lacave, J L Fernández, et al.
Gynecologic Oncology|June 1, 1990
Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG)K R Durrant, C Mangioni, A J Lacave, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group studyJ B Vermorken, G Zanetta, C F De Oliveira, et al.
The New England Journal of Medicine|March 9, 1995
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of CancerM E van der Burg, M van Lent, M Buyse, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group StudyC F de Oliveira, A J Lacave, C Villani, et al.
Pageof 7